Clara, 43, discovered a small lump during a self-exam in 2023, leading to a stage I breast cancer diagnosis. “I panicked, but my doctor recommended a lumpectomy followed by targeted radiation—no chemo needed,” she says. Genetic testing confirmed low recurrence risk, easing her anxiety.
“My coach connected me with a support group for early-stage patients, which helped normalize the fear,” Clara explains. She paired treatment with gentle yoga to manage stress. “Six months post-surgery, I’m clear. Early detection truly is a game-changer.”
She advises: “Don’t skip screenings. Catching it early opens up so many more options—and hope.”

Elena, 38, a marketing executive from Moscow, found a small lump during a self-exam in 2022. A biopsy confirmed stage I breast cancer. “I panicked—my mother had died from breast cancer, so I feared the worst,” she says.
Her oncologist recommended CTC testing to guide treatment. “The results showed my cancer was slow-growing and responsive to hormone therapy, so we avoided aggressive chemo,” Elena explains. She supplemented with IV nutrient therapy and worked with a virtual coach to manage stress through meditation.
Now 18 months post-treatment, Elena’s scans are clear. “Living in Russia, I worried about access to personalized care, but the CTC test changed that. It let my team tailor a plan that respected my body and my life. I’m back at work, traveling, and cherishing every moment.”
She advises: “Don’t let fear make decisions for you. Ask for tests that show your cancer’s behavior—not just statistics. It made all the difference.”